223 related articles for article (PubMed ID: 31374487)
1. Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial.
Ferreira JA; Le Pichon JB; Abdelmoity AT; Dilley D; Dedeken P; Daniels T; Byrnes W
Seizure; 2019 Oct; 71():166-173. PubMed ID: 31374487
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes.
Baulac M; Coulbaut S; Doty P; McShea C; De Backer M; Bartolomei F; Vlaicu M
Epileptic Disord; 2017 Jun; 19(2):186-194. PubMed ID: 28597842
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial.
Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z
Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures.
Farkas V; Steinborn B; Flamini JR; Zhang Y; Yuen N; Borghs S; Bozorg A; Daniels T; Martin P; Carney HC; Dimova S; Scheffer IE;
Neurology; 2019 Sep; 93(12):e1212-e1226. PubMed ID: 31462582
[TBL] [Abstract][Full Text] [Related]
9. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.
Farkas MK; Beller C; Bozorg A; McClung C; Roebling R; Yates T; Yuen N; Makedonska I
Epilepsia Open; 2023 Mar; 8(1):146-153. PubMed ID: 36529709
[TBL] [Abstract][Full Text] [Related]
11. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
[TBL] [Abstract][Full Text] [Related]
13. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
[TBL] [Abstract][Full Text] [Related]
15. Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study.
Wechsler RT; Li G; French J; O'Brien TJ; D'Cruz O; Williams P; Goodson R; Brock M;
Epilepsia; 2014 Jul; 55(7):1088-98. PubMed ID: 24915838
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
18. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of adjunctive lacosamide in patients aged <4 years with focal seizures.
Makedonska I; Ng YT; Beller C; Bozorg A; Csikós J; McClung C; Moeltgen H; Farkas MK;
Ann Clin Transl Neurol; 2024 Mar; 11(3):768-779. PubMed ID: 38375995
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Ben-Menachem E; Grebe HP; Terada K; Jensen L; Li T; De Backer M; Steiniger-Brach B; Gasalla T; Brock M; Biton V
Epilepsia; 2019 Dec; 60(12):2437-2447. PubMed ID: 31755090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
